These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

542 related items for PubMed ID: 9701332

  • 1. Posttransplant lymphoproliferative disorder in pediatric bone marrow transplant recipients: disseminated disease of donor origin demonstrated by fluorescence in situ hybridization.
    Lones MA, Lopez-Terrada D, Shintaku IP, Rosenthal J, Said JW.
    Arch Pathol Lab Med; 1998 Aug; 122(8):708-14. PubMed ID: 9701332
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Posttransplant lymphoproliferative disorder in a kidney-pancreas transplanted recipient: simultaneous development of clonal lymphoid B-cell proliferation of host and donor origin.
    Heyny-von Haussen R, Klingel K, Riegel W, Kandolf R, Mall G.
    Am J Surg Pathol; 2006 Jul; 30(7):900-5. PubMed ID: 16819335
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. In situ hybridization for the Y chromosome reveals a donor origin for a posttransplant lymphoproliferative disorder in a sex-mismatched hepatic allograft.
    Hegele RG, Bicknell SG, Bailey DJ, Cameron RG.
    Arch Pathol Lab Med; 1994 Aug; 118(8):795-6. PubMed ID: 8060227
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Fine-needle aspiration cytology of lymphoproliferative disorders in the immunosuppressed patient: the diagnostic utility of in situ hybridization for Epstein-Barr virus.
    Hecht JL, Cibas ES, Kutok JL.
    Diagn Cytopathol; 2002 Jun; 26(6):360-5. PubMed ID: 12112825
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Bone marrow involvement in patients with posttransplant lymphoproliferative disorders: incidence and prognostic factors.
    Montanari F, O'Connor OA, Savage DG, Zain JM, Venkatraman S, McCormick EK, Crook MT, Tsao L, Sevilla DW, Bhagat G, Alobeid B.
    Hum Pathol; 2010 Aug; 41(8):1150-8. PubMed ID: 20381113
    [Abstract] [Full Text] [Related]

  • 11. Posttransplant Hodgkin lymphoma preceded by polymorphic posttransplant lymphoproliferative disorder: report of a pediatric case and review of the literature.
    Gheorghe G, Albano EA, Porter CC, McGavran L, Wei Q, Meltesen L, Danielson SM, Liang X.
    J Pediatr Hematol Oncol; 2007 Feb; 29(2):112-6. PubMed ID: 17279008
    [Abstract] [Full Text] [Related]

  • 12. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus.
    Hanto DW, Frizzera G, Purtilo DT, Sakamoto K, Sullivan JL, Saemundsen AK, Klein G, Simmons RL, Najarian JS.
    Cancer Res; 1981 Nov; 41(11 Pt 1):4253-61. PubMed ID: 6272971
    [Abstract] [Full Text] [Related]

  • 13. Epstein-Barr virus (EBV)-associated post-transplantation lymphoproliferative disorder simultaneously affecting both B and T cells after allogeneic bone marrow transplantation.
    Chuhjo T, Yachie A, Kanegane H, Kimura H, Shiobara S, Nakao S.
    Am J Hematol; 2003 Apr; 72(4):255-8. PubMed ID: 12666136
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Posttransplant lymphoproliferative disorder after liver and kidney transplant.
    Akar Özkan E, Özdemir BH, Deniz EE, Tunca MZ, Haberal M.
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():142-8. PubMed ID: 24635813
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Identification of Epstein-Barr virus lytic activity in post-transplantation lymphoproliferative disease.
    Montone KT, Hodinka RL, Salhany KE, Lavi E, Rostami A, Tomaszewski JE.
    Mod Pathol; 1996 Jun; 9(6):621-30. PubMed ID: 8782198
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.
    Gulley ML, Swinnen LJ, Plaisance KT, Schnell C, Grogan TM, Schneider BG, Southwest Oncology Group.
    Transplantation; 2003 Sep 27; 76(6):959-64. PubMed ID: 14508361
    [Abstract] [Full Text] [Related]

  • 20. Simian virus 40 in posttransplant lymphoproliferative disorders.
    Vilchez RA, Jauregui MP, Hsi ED, Novoa-Takara L, Chang CC.
    Hum Pathol; 2006 Sep 27; 37(9):1130-6. PubMed ID: 16938517
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.